SEC Comment Letter for Rezolute, Inc. (RZLT) (CIK 0001509261) (RZLT) — Nov 6, 2017
Rezolute, Inc. (RZLT) (CIK 0001509261)
Date: Nov. 6, 2017 · CIK: 0001509261 · Accession: 0000000000-17-039153
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-220585
Letter
November 6, 2017 Nevan Elam Chief Executive Officer AntriaBio, Inc. 1450 Infinite Drive Louisville, CO 80027 Re:AntriaBio, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed October 31, 2017 File No. 333-220585 Dear Mr. Elam: We have reviewed your amended registration statement and have the following comment. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to the comment, we may have additional comments. Amendment No. 1 to Registration Statement on Form S-1 Documents Incorporated by Reference, page 30 1.Please revise your incorporation by reference section to incorporate the Form 8-K filed on November 3, 2017.
FirstName LastNameNevan Elam Comapany NameAntriaBio, Inc. June 16, 2017 Page 2 FirstName LastName Nevan Elam AntriaBio, Inc. November 6, 2017 Page 2 Please contact Dorrie Yale at 202-551-8776 or Suzanne Hayes at 202-551-3675 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Michael L. Weiner
Show Raw Text
November 6, 2017
Nevan Elam
Chief Executive Officer
AntriaBio, Inc.
1450 Infinite Drive
Louisville, CO 80027
Re:AntriaBio, Inc.
Amendment No. 1 to Registration Statement on Form S-1
Filed October 31, 2017
File No. 333-220585
Dear Mr. Elam:
We have reviewed your amended registration statement and have the following
comment. In some of our comments, we may ask you to provide us with information so we may
better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to the comment, we may have additional comments.
Amendment No. 1 to Registration Statement on Form S-1
Documents Incorporated by Reference, page 30
1.Please revise your incorporation by reference section to incorporate the Form 8-K filed
on November 3, 2017.
FirstName LastNameNevan Elam
Comapany NameAntriaBio, Inc.
June 16, 2017 Page 2
FirstName LastName
Nevan Elam
AntriaBio, Inc.
November 6, 2017
Page 2
Please contact Dorrie Yale at 202-551-8776 or Suzanne Hayes at 202-551-3675 with any
questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Michael L. Weiner